NSAIDs and hepatic reactions [9]

Lancet

Volumn 353, Issue 9155, 1999, Pages 846-

  Villa, G ^a  

^a HELSINN HEALTHCARE SA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT;

DRUG METABOLISM; HUMAN; LETTER; LIVER FAILURE; LIVER TOXICITY; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0033528512     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)76667-8     Document Type: Letter

References (4)

1. PA McCormick F Kennedy M Curry O Traynor COX-2 inhibitor and fulminant hepatic failure Lancet 353 1989 40 41
2. KD Rainsford An analysis from clinico-epidemiological data of the principal adverse events from the COX-2 selective NSAID, nimesulide, with particular reference to hepatic injury Inflammopharmacology 6 1998 203 221
3. M Levy Z Ackerman Liver toxicity of antipyretic drugs in conjunction with measles infection Rainsford KD Velo GP Inflammation and drug therapy series, vol V: side-efffects of anti-inflammatory drugs 3. 1992 Kluwer Academic Publishers Dordrecht 207
4. UA Boelsterli HJ Zimmerman A Kretz-Rommel Idiosyncratic liver toxicity of nonsteroidal antiinflammatory drugs: molecular mechanisms and pathology Crit Rev Toxicol 25 1995 207 235